Chargement en cours...
Iterative Design of Emetine-Based Prodrug Targeting Fibroblast Activation Protein (FAP) and Dipeptidyl Peptidase IV DPPIV Using a Tandem Enzymatic Activation Strategy
BACKGROUND. There is an urgent need to develop new agents for treating metastatic prostate cancer to overcome multiple drug resistance to the current standard targeted cancer therapy. Emetine is a highly cytotoxic natural product protein synthesis inhibitor, which is toxic to all cell types. Its cyt...
Enregistré dans:
| Publié dans: | Prostate |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6432629/ https://ncbi.nlm.nih.gov/pubmed/26835873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.23162 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|